RBC Capital Markets adjusted their financial outlook on CGI Group (NYSE:GIB), increasing the price target to $192.00, up from the previous $178.00, while keeping a positive Outperform rating on the shares.

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his tenure.

RBC Capital Markets adjusted their outlook on Lennox International (NYSE:LII), a global provider of climate control solutions. Analyst Deane Dray at RBC Capital increased the price target for Lennox International to $642 from the previous target of $617,

J.M. Smucker Co. chief executive Mark Smucker leaned on close advisers when he made the decision to bolster the jelly and coffee company through a US$5.6-billion acquisition in 2023 of Hostess Brands Inc., an equally well-known name in food, and they came from a seemingly unusual place: a Canadian bank.

RBC Capital analyst Douglas Miehm assigned a Hold rating to Bausch Health Companies (BHC – Research Report) today and set a price target of

Find insight on United Utilities, Viva Energy, Valero Energy and more in the latest Market Talks covering Energy and Utilities.

Infinity is going public after more than doubling its revenue in the first nine months of 2024. The strong growth came as the company's oil production volumes benefited from wells acquired from Utica Resources Ventures and PEO Ohio in October for $279 million.

RBC Capital lowered the firm’s price target on Bausch Health (BHC) to $10 from $11 and keeps a Sector Perform rating on the shares ahead of its

Microsoft's disappointing Azure numbers are "neutral to modestly negative" for rivals Amazon.com and Alphabet, according to RBC Capital Markets analyst Brad Erickson. Alphabet stock rose 1% while Amazon's was marginally lower.

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within the bank. Through summer jobs and co-op placements, as well as internships, they gain practical work experience and learn about RBC’s extensive career opportunities.

RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.

In a report released on January 29, Brad Erickson from RBC Capital maintained a Buy rating on Alphabet Class A (GOOGL – Research Report), with